Your browser doesn't support javascript.
loading
Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes.
Li, JingWei; Woodward, Mark; Perkovic, Vlado; Figtree, Gemma A; Heerspink, Hiddo J L; Mahaffey, Kenneth W; de Zeeuw, Dick; Vercruysse, Frank; Shaw, Wayne; Matthews, David R; Neal, Bruce.
Affiliation
  • Li J; Department of Cardiology, People's Liberation Army General Hospital, Beijing, China; Department of Cardiology, Xinqiao Hospital, Army Military Medical University, Chongqing, China; George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Woodward M; George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; University of Oxford, Oxford, United Kingdom; Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland.
  • Perkovic V; George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
  • Figtree GA; Kolling Institute, Royal North Shore Hospital, Sydney, New South Wales, Australia; Faculty of Medicine and Health, University of Sydney, New South Wales, Australia.
  • Heerspink HJL; George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Mahaffey KW; Department of Medicine, Stanford Center for Clinical Research, Stanford University School of Medicine, Stanford, California.
  • de Zeeuw D; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Vercruysse F; Janssen Research and Development, Beerse, Belgium.
  • Shaw W; Janssen Research & Development, Raritan, New Jersey.
  • Matthews DR; Oxford Centre for Diabetes, Endocrinology and Metabolism and Harris Manchester College, University of Oxford, United Kingdom.
  • Neal B; George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia; Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia; Imperial College London, London, United Kingdom. Electronic address: bneal@georgeinstitute.org.au.
JACC Heart Fail ; 8(1): 57-66, 2020 01.
Article in En | MEDLINE | ID: mdl-31676303
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Canagliflozin / Heart Failure Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: JACC Heart Fail Year: 2020 Document type: Article Affiliation country: Australia Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Canagliflozin / Heart Failure Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: JACC Heart Fail Year: 2020 Document type: Article Affiliation country: Australia Country of publication: United States